{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T22:49:39Z","timestamp":1783810179352,"version":"3.55.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00520-019-05012-8","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T14:44:33Z","timestamp":1565102673000},"page":"13-21","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Revisiting the physiology of nausea and vomiting\u2014challenging the paradigm"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9878-9964","authenticated-orcid":false,"given":"Rita J.","family":"Wickham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"issue":"suppl 1","key":"5012_CR1","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1007\/s00520-018-4131-3","volume":"26","author":"M Aapro","year":"2018","unstructured":"Aapro M (2018) CINV: still troubling patients after all these years. Support Care Cancer 26(suppl 1):S5\u2013S9. \nhttps:\/\/doi.org\/10.1007\/s00520-018-4131-3","journal-title":"Support Care Cancer"},{"key":"5012_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00520-018-4323-x","volume":"27","author":"DS Childs","year":"2019","unstructured":"Childs DS, Looker S, Le-Rademacher J et al (2019) What occurs in the other 20% of cancer patients with chemotherapy-induced nausea and vomiting (CINV)? A single-institution qualitative study. Support Care Cancer 27:249\u2013255. \nhttps:\/\/doi.org\/10.1007\/s00520-018-4323-x","journal-title":"Support Care Cancer"},{"key":"5012_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1177\/1756283X15618131","volume":"9","author":"P Singh","year":"2016","unstructured":"Singh P, Yoon SS, Kuo B (2016) Nausea: a review of pathophysiology and therapeutics. Ther Adv Gastroenterol 9:98\u2013112. \nhttps:\/\/doi.org\/10.1177\/1756283X15618131","journal-title":"Ther Adv Gastroenterol"},{"key":"5012_CR4","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1007\/s00520-015-3071-4","volume":"24","author":"HS Donovan","year":"2016","unstructured":"Donovan HS, Hagan TL, Campbell GB, Boisen MM, Rosenblum LM, Edwards RP, Bovbjerg DH, Horn CC (2016) Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysis. Support Care Cancer 24:2635\u20132642. \nhttps:\/\/doi.org\/10.1007\/s00520-015-3071-4","journal-title":"Support Care Cancer"},{"key":"5012_CR5","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1634\/theoncologist.2014-0438","volume":"20","author":"TL Ng","year":"2015","unstructured":"Ng TL, Hutton B, Clemons M (2015) Chemotherapy-induced nausea and vomiting: time for more emphasis on nausea? Oncologist 20:576\u2013583. \nhttps:\/\/doi.org\/10.1634\/theoncologist.2014-0438","journal-title":"Oncologist"},{"key":"5012_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00520-018-4326-7","volume":"27","author":"SL Harder","year":"2019","unstructured":"Harder SL, Groenvold M, Herrstedt J, Johnsen AT (2019) Nausea in advanced cancer: relationships between intensity, burden, and the need for help. Support Care Cancer 27:265\u2013273. \nhttps:\/\/doi.org\/10.1007\/s00520-018-4326-7","journal-title":"Support Care Cancer"},{"key":"5012_CR7","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.2174\/13816128113199990568","volume":"20","author":"CC Horn","year":"2014","unstructured":"Horn CC (2014) The medical implications of gastrointestinal vagal afferent pathways in nausea and vomiting. Curr Pharm Des 20:2703\u20132712. \nhttps:\/\/doi.org\/10.2174\/13816128113199990568","journal-title":"Curr Pharm Des"},{"key":"5012_CR8","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1007\/s00520-015-2801-y","volume":"23","author":"CH Torres","year":"2015","unstructured":"Torres CH, Mazzarello S, Ng T et al (2015) Defining optimal control of chemotherapy-induced nausea and vomiting\u2014based on patients\u2019 experience. Support Care Cancer 23:3341\u20133359. \nhttps:\/\/doi.org\/10.1007\/s00520-015-2801-y","journal-title":"Support Care Cancer"},{"issue":"4","key":"5012_CR9","doi-asserted-by":"publisher","first-page":"ENEURO.0256-18.","DOI":"10.1523\/ENEURO.0256-18.2018","volume":"5","author":"Cheryl L. Limebeer","year":"2018","unstructured":"Limebeer CL, Rock EM, Sharkey KA, Parker LA (2018) Nausea-induced 5-HT release in the interoceptive insular cortex and regulation by monoacylglycerol lipase (MAGL) inhibition and cannabidiol. eNeuro 5(4). \nhttps:\/\/doi.org\/10.1523\/ENEURO.0256-18.2018","journal-title":"eneuro"},{"key":"5012_CR10","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3389\/fphar.2018.00913","volume":"9","author":"GJ Sanger","year":"2018","unstructured":"Sanger GJ, Andrews PLR (2018) A history of drug discovery for treatment of nausea and vomiting and the implications for future research. Front Pharmacol 9:913. Published online Sept 4, 2018. \nhttps:\/\/doi.org\/10.3389\/fphar.2018.00913","journal-title":"Front Pharmacol"},{"key":"5012_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.autneu.2016.07.003","volume":"202","author":"CD Balaban","year":"2017","unstructured":"Balaban CD, Yates BJ (2017) What is nausea? A historical analysis of changing views. Auton Neurosci 202:5\u201317. \nhttps:\/\/doi.org\/10.1016\/j.autneu.2016.07.003","journal-title":"Auton Neurosci"},{"key":"5012_CR12","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/cercor\/bhs073","volume":"23","author":"V Napadow","year":"2013","unstructured":"Napadow V, Sheehan JD, Kim J, LaCount LT, Park K, Kaptchuk TJ, Rosen BR, Kuo B (2013) The brain circuitry underlying the temporal evolution of nausea in humans. Cereb Cortex 23:806\u2013813. \nhttps:\/\/doi.org\/10.1093\/cercor\/bhs073","journal-title":"Cereb Cortex"},{"key":"5012_CR13","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1007\/s00221-014-4007-9","volume":"232","author":"KL Koch","year":"2014","unstructured":"Koch KL (2014) Gastric dysrhythmias: a potential objective measure of nausea. Exp Brain Res 232:2553\u20132561. \nhttps:\/\/doi.org\/10.1007\/s00221-014-4007-9","journal-title":"Exp Brain Res"},{"key":"5012_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.molmet.2015.03.005","volume":"4","author":"TD M\u00fcller","year":"2015","unstructured":"M\u00fcller TD, Nogueiras R, Andermann ML (2015) Ghrelin. Molecular Metabolism 4:437\u2013460. \nhttps:\/\/doi.org\/10.1016\/j.molmet.2015.03.005","journal-title":"Molecular Metabolism"},{"key":"5012_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s10147-011-0289-0","volume":"17","author":"Y Hiura","year":"2012","unstructured":"Hiura Y, Takiguchi S, Yamamoto K, Kurokawa Y, Yamasaki M, Nakajima K, Miyata H, Fujiwara Y, Mori M, Doki Y (2012) Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients. Int J Clin Oncol 17:316\u2013323. \nhttps:\/\/doi.org\/10.1007\/s10147-011-0289-0","journal-title":"Int J Clin Oncol"},{"key":"5012_CR16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1365-2036.2010.04567.x","volume":"33","author":"JM Wo","year":"2011","unstructured":"Wo JM, Ejskjaer N, Hellstrom PM et al (2011) Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting \u2013 randomised clinical study subset data. Aliment Pharmacol Ther 33:679\u2013688. \nhttps:\/\/doi.org\/10.1111\/j.1365-2036.2010.04567.x","journal-title":"Aliment Pharmacol Ther"},{"key":"5012_CR17","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3389\/fphar.2018.00869","volume":"9","author":"JA Rudd","year":"2018","unstructured":"Rudd JA, Chan SW, Ngan MP, Tu L, Lu Z, Giuliano C, Lovati E, Pietra C (2018) Anti-emetic action of the brain-penetrating new ghrelin agonist, HM01, alone and in combination with the 5-HT3 antagonist, palonosetron and with the NK1 antagonist, netupitant, against cisplatin- and motion-induced emesis in Suncus murinus (house musk shrew). Front Pharmacol 9:869. \nhttps:\/\/doi.org\/10.3389\/fphar.2018.00869","journal-title":"Front Pharmacol"},{"key":"5012_CR18","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1365-2982.2010.01483.x","volume":"22","author":"PA Cabezos","year":"2010","unstructured":"Cabezos PA, Vera G, Martin-Fontelles MI et al (2010) Cisplatin-induced gastrointestinal dysmotility is aggravated after chronic administration in the rat. Comparison with pica. Neurogastroenterol Motil 22:797\u2013805, 797-e225. \nhttps:\/\/doi.org\/10.1111\/j.1365-2982.2010.01483.x","journal-title":"Neurogastroenterol Motil"},{"key":"5012_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1089\/can.2016.0006","volume":"1","author":"EM Rock","year":"2016","unstructured":"Rock EM, Sticht MA, Limebeer CL, Parker LA (2016) Cannabinoid regulation of acute and anticipatory nausea. Cannabis Cannabinoid Res 1:113\u2013121. \nhttps:\/\/doi.org\/10.1089\/can.2016.0006","journal-title":"Cannabis Cannabinoid Res"},{"key":"5012_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/nyas.13969","volume":"1428","author":"N Weltens","year":"2018","unstructured":"Weltens N, Iven J, Van Oudenhove L, Kano M (2018) The gut\u2013brain axis in health neuroscience: implications for functional gastrointestinal disorders and appetite regulation. Ann N Y Acad Sci 1428:129\u2013150. \nhttps:\/\/doi.org\/10.1111\/nyas.13969","journal-title":"Ann N Y Acad Sci"},{"key":"5012_CR21","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1097\/01.scs.0000180285.51365.55","volume":"41","author":"M Schemann","year":"2005","unstructured":"Schemann M (2005) Control of gastrointestinal motility by the \u201cgut brain\u201d \u2014 the enteric nervous system. J Pediatr Gastroenterol Nutr 41:S4\u2013S6","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"5012_CR22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.neuron.2013.02.008","volume":"77","author":"HD Critchley","year":"2013","unstructured":"Critchley HD, Harrison NA (2013) Visceral influences on brain and behavior. Neuron 77:624\u2013638. \nhttps:\/\/doi.org\/10.1016\/j.neuron.2013.02.008","journal-title":"Neuron"},{"issue":"Suppl 2","key":"5012_CR23","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1093\/annonc\/12.suppl_2.S63","volume":"12","author":"H Ahlman","year":"2001","unstructured":"Ahlman H, Nilsson O (2001) The gut as the largest endocrine organ in the body. Ann Oncol 12(Suppl 2):S63\u2013S68","journal-title":"Ann Oncol"},{"key":"5012_CR24","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s11894-010-0129-9","volume":"12","author":"BG Nezami","year":"2010","unstructured":"Nezami BG, Srinivasan S (2010) Enteric nervous system in the small intestine: pathophysiology and clinical implications. Curr Gastroenterol Rep 12:358\u2013365. \nhttps:\/\/doi.org\/10.1007\/s11894-010-0129-9","journal-title":"Curr Gastroenterol Rep"},{"key":"5012_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cell.2017.05.034","volume":"170","author":"NW Bellono","year":"2017","unstructured":"Bellono NW, Bayrer JR, Leitch DB, Castro J, Zhang C, O\u2019Donnell TA, Brierley SM, Ingraham HA, Julius D (2017) Enterochromaffin cells are gut chemosensors that couple to sensory neural pathways. Cell 170:185\u2013198. \nhttps:\/\/doi.org\/10.1016\/j.cell.2017.05.034","journal-title":"Cell"},{"key":"5012_CR26","doi-asserted-by":"publisher","first-page":"e13101","DOI":"10.1111\/nmo.13101","volume":"29","author":"S Diwakarla","year":"2017","unstructured":"Diwakarla S, Fothergill LJ, Fakhry J, Callaghan B, Furness JB (2017) Heterogeneity of enterochromaffin cells within the gastrointestinal tract. Neurogastroenterol Motil 29:e13101\u2013ee1315. \nhttps:\/\/doi.org\/10.1111\/nmo.13101","journal-title":"Neurogastroenterol Motil"},{"key":"5012_CR27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00210-018-1493-5","volume":"391","author":"Y Obara","year":"2018","unstructured":"Obara Y, Machida T, Takano Y, Shiga S, Suzuki A, Hamaue N, Iizuka K, Hirafuji M (2018) Cisplatin increases the number of enterochromaffin cells containing substance P in rat intestine. Naunyn Schmiedeberg's Arch Pharmacol 391:847\u2013858. \nhttps:\/\/doi.org\/10.1007\/s00210-018-1493-5","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"issue":"32","key":"5012_CR28","doi-asserted-by":"publisher","first-page":"E7632","DOI":"10.1073\/pnas.1804938115","volume":"115","author":"C Alcaino","year":"2018","unstructured":"Alcaino C, Knutson KR, Treichel AJ, Yildiz G, Strege PR, Linden DR, Li JH, Leiter AB, Szurszewski JH, Farrugia G, Beyder A (2018) A population of gut epithelial enterochromaffin cells is mechanosensitive and requires Piezo2 to convert force into serotonin release. Proc Natl Acad Sci U S A 115(32):E7632\u2013E7641. \nhttps:\/\/doi.org\/10.1073\/pnas.1804938115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5012_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejphar.2013.08.047","volume":"722","author":"T Babic","year":"2014","unstructured":"Babic T, Browning KN (2014) The role of vagal neurocircuits in the regulation of nausea and vomiting. Eur J Pharmacol 722:38\u201347. \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2013.08.047","journal-title":"Eur J Pharmacol"},{"key":"5012_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.autneu.2016.07.006","volume":"202","author":"W Zhong","year":"2017","unstructured":"Zhong W, Picca AJ, Lee AS, Darmani NA (2017) Ca2+ signaling and emesis: recent progress and new perspectives. Auton Neurosci 202:18\u201327. \nhttps:\/\/doi.org\/10.1016\/j.autneu.2016.07.006","journal-title":"Auton Neurosci"},{"key":"5012_CR31","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1111\/bph.12629","volume":"171","author":"K Yamamoto","year":"2014","unstructured":"Yamamoto K, Asano K, Tasaka A, Ogura Y, Kim S, Ito Y, Yamatodani A (2014) Involvement of substance P in the development of cisplatin-induced acute and delayed pica in rats. Brit J Pharmacol 171:2888\u20132899. \nhttps:\/\/doi.org\/10.1111\/bph.12629","journal-title":"Brit J Pharmacol"},{"key":"5012_CR32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ejphar.2008.04.050","volume":"589","author":"C Ju","year":"2008","unstructured":"Ju C, Hamaue N, Machida T, Liu Y, Iizuka K, Wang Y, Minami M, Hirafuji M (2008) Anti-inflammatory drugs ameliorate opposite enzymatic changes in ileal 5-hydroxytryptamine metabolism in the delayed phase after cisplatin administration to rats. Eur J Pharmacol 589:281\u2013287. \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2008.04.050","journal-title":"Eur J Pharmacol"},{"key":"5012_CR33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jphs.2017.02.009","volume":"133","author":"T Machida","year":"2017","unstructured":"Machida T, Takano Y, Iizuka K, Machida M, Hirafuji M (2017) Methotrexate causes acute hyperplasia of enterochromaffin cells containing substance P in the intestinal mucosa of rats. J Pharmacol Sci 133:190\u2013193. \nhttps:\/\/doi.org\/10.1016\/j.jphs.2017.02.009","journal-title":"J Pharmacol Sci"},{"key":"5012_CR34","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nrgastro.2016.76","volume":"13","author":"RA Travagli","year":"2016","unstructured":"Travagli RA, Anselmi L (2016) Vagal neurocircuitry and its influence on gastric motility. Nat Rev Gastroenterol Hepatol 13:389\u2013401. \nhttps:\/\/doi.org\/10.1038\/nrgastro.2016.76","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1-2","key":"5012_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.autneu.2006.07.020","volume":"129","author":"ER Muth","year":"2006","unstructured":"Muth ER (2006) Motion and space sickness: intestinal and autonomic correlates. Auton Neurosci 129(1-2):58\u201366. \nhttps:\/\/doi.org\/10.1016\/j.autneu.2006.07.020","journal-title":"Auton Neurosci"},{"key":"5012_CR36","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1007\/s00221-014-4008-8","volume":"232","author":"JR Lackner","year":"2014","unstructured":"Lackner JR (2014) Motion sickness: more than nausea and vomiting. Exp Brain Res 232:2493\u20132510. \nhttps:\/\/doi.org\/10.1007\/s00221-014-4008-8","journal-title":"Exp Brain Res"},{"key":"5012_CR37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.autneu.2016.10.003","volume":"202","author":"N Toschi","year":"2017","unstructured":"Toschi N, Kim J, Sclocco R, Duggento A, Barbieri R, Kuo B, Napadow V (2017) Motion sickness increases functional connectivity between visual motion and nausea-associated brain regions. Auton Neurosci 202:108\u2013113. \nhttps:\/\/doi.org\/10.1016\/j.autneu.2016.10.003","journal-title":"Auton Neurosci"},{"key":"5012_CR38","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1212\/WNL.0000000000003751","volume":"88","author":"JK Cutsforth-Gregory","year":"2017","unstructured":"Cutsforth-Gregory JK, Benarroch EE (2017) Nucleus of the solitary tract, medullary reflexes, and clinical implications. Neurology 88:1187\u20131196. \nhttps:\/\/doi.org\/10.1212\/WNL.0000000000003751","journal-title":"Neurology"},{"key":"5012_CR39","doi-asserted-by":"publisher","first-page":"879","DOI":"10.14670\/HH-11-881","volume":"32","author":"C Kaur","year":"2017","unstructured":"Kaur C, Ling E-A (2017) The circumventricular organs. Histol Histopathol 32:879\u2013892. \nhttps:\/\/doi.org\/10.14670\/HH-11-881","journal-title":"Histol Histopathol"},{"key":"5012_CR40","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/1073858407311100","volume":"14","author":"CJ Price","year":"2008","unstructured":"Price CJ, Hoyda TD, Ferguson AV (2008) The area postrema: a brain monitor and integrator of systemic autonomic state. Neuroscientist 14:182\u2013194. \nhttps:\/\/doi.org\/10.1177\/1073858407311100","journal-title":"Neuroscientist"},{"key":"5012_CR41","doi-asserted-by":"publisher","unstructured":"Miyata S (2015) New aspects in fenestrated capillary and tissue dynamics in the sensory circumventricular organs of adult brains. Front Neurosci 9:\u2013390. \nhttps:\/\/doi.org\/10.3389\/fnins.2015.00390","DOI":"10.3389\/fnins.2015.00390"},{"key":"5012_CR42","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s11064-008-9676-y","volume":"33","author":"Q-P Wang","year":"2008","unstructured":"Wang Q-P, Guan J-L, Pan W, Kastin AJ, Shioda S (2008) A diffusion barrier between the area postrema and nucleus tractus solitarius. Neurochem Res 33:2035\u20132043. \nhttps:\/\/doi.org\/10.1007\/s11064-008-9676-y","journal-title":"Neurochem Res"},{"key":"5012_CR43","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1124\/jpet.111.188797","volume":"33","author":"C-L Chin","year":"2006","unstructured":"Chin C-L, Fox GB, Hradil VP et al (2006) Pharmacological MRI in awake rats reveals neural activity in area postrema and nucleus tractus solitarius: relevance as a potential biomarker for detecting drug-induced emesis. NeuroImage 33:1152\u20131160. \nhttps:\/\/doi.org\/10.1124\/jpet.111.188797","journal-title":"NeuroImage"},{"key":"5012_CR44","doi-asserted-by":"crossref","unstructured":"Craig AD (2015) How do you feel? (pp 130\u2013181). Princeton University Press","DOI":"10.1515\/9781400852727"},{"issue":"10","key":"5012_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/nmo.13096","volume":"29","author":"X Sun","year":"2017","unstructured":"Sun X, Xu L, Guo F, Luo W, Gao S, Luan X (2017) Neurokinin-1 receptor blocker CP-99 94 improved emesis induced by cisplatin via regulating the activity of gastric distention responsive neurons in the dorsal motor nucleus of vagus and enhancing gastric motility in rats. Neurogastroenterol Motil 29(10):1\u201311. \nhttps:\/\/doi.org\/10.1111\/nmo.13096","journal-title":"Neurogastroenterol Motil"},{"key":"5012_CR46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.neuropharm.2015.10.039","volume":"102","author":"MA Stich","year":"2016","unstructured":"Stich MA, Limebeer CL, Rafla BR et al (2016) Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex. Neuropharmacol 102:92\u2013102. \nhttps:\/\/doi.org\/10.1016\/j.neuropharm.2015.10.039","journal-title":"Neuropharmacol"},{"issue":"5","key":"5012_CR47","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1113\/jphysiol.2014.284240","volume":"593","author":"AD Farmer","year":"2015","unstructured":"Farmer AD, Ban VF, Coen SJ, Sanger GJ, Barker GJ, Gresty MA, Giampietro VP, Williams SC, Webb DL, Hellstr\u00f6m PM, Andrews PLR, Aziz Q (2015) Visually induced nausea causes characteristic changes in cerebral, autonomic and endocrine function in humans. J Physiol 593(5):1183\u20131196. \nhttps:\/\/doi.org\/10.1113\/jphysiol.2014.284240","journal-title":"J Physiol"},{"key":"5012_CR48","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/cercor\/bhu172","volume":"26","author":"R Sclocco","year":"2016","unstructured":"Sclocco R, Kim J, Garcia RG, Sheehan JD, Beissner F, Bianchi AM, Cerutti S, Kuo B, Barbieri R, Napadow V (2016) Brain circuitry supporting multi-organ autonomic outflow in response to nausea. Cereb Cortex 26:485\u2013497. \nhttps:\/\/doi.org\/10.1093\/cercor\/bhu172","journal-title":"Cereb Cortex"},{"key":"5012_CR49","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/WNP.0000000000000377","volume":"34","author":"LQ Uddin","year":"2017","unstructured":"Uddin LQ, Nomi JS, Hebert-Seropian B et al (2017) Structure and function of the human insula. J Clin Neurophysiol 34:300\u2013306. \nhttps:\/\/doi.org\/10.1097\/WNP.0000000000000377","journal-title":"J Clin Neurophysiol"},{"key":"5012_CR50","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tins.2017.02.002","volume":"40","author":"H Namkung","year":"2017","unstructured":"Namkung H, Kim S-H, Sawa A (2017) The insula: an underestimated brain area in clinical neuroscience, psychiatry, and neurology. Trends Neurosci 40:200\u2013207. \nhttps:\/\/doi.org\/10.1016\/j.tins.2017.02.002","journal-title":"Trends Neurosci"},{"key":"5012_CR51","doi-asserted-by":"publisher","first-page":"R573","DOI":"10.1016\/j.cub.2017.05.010","volume":"27","author":"N Gogolla","year":"2017","unstructured":"Gogolla N (2017) The insular cortex. Curr Biol 27:R573\u2013R591. \nhttps:\/\/doi.org\/10.1016\/j.cub.2017.05.010","journal-title":"Curr Biol"},{"key":"5012_CR52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrn2555","volume":"10","author":"AD Craig","year":"2009","unstructured":"Craig AD (2009) How do you feel \u2014 now? The anterior insula and human awareness. Nat Rev Neurosci 10:59\u201370. \nhttps:\/\/doi.org\/10.1038\/nrn2555","journal-title":"Nat Rev Neurosci"},{"issue":"7534","key":"5012_CR53","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nature14188","volume":"517","author":"PH Janak","year":"2015","unstructured":"Janak PH, Tye KM (2015) From circuits to behaviour in the amygdala. Nature 517(7534):284\u2013292. \nhttps:\/\/doi.org\/10.1038\/nature14188","journal-title":"Nature"},{"key":"5012_CR54","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1212\/WNL.0000000000002393","volume":"86","author":"EE Benarroch","year":"2016","unstructured":"Benarroch EE (2016) Parabrachial nuclear complex: multiple functions and potential clinical implications. Neurology 86:676\u2013683. \nhttps:\/\/doi.org\/10.1212\/WNL.0000000000002393","journal-title":"Neurology"},{"key":"5012_CR55","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00520-012-1574-9","volume":"21","author":"C Pirri","year":"2013","unstructured":"Pirri C, Bayliss E, Trotter J, Olver IN, Katris P, Drummond P, Bennett R (2013) Nausea still the poor relation in antiemetic therapy? The impact on cancer patients\u2019 quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster. Support Care Cancer 21:735\u2013748. \nhttps:\/\/doi.org\/10.1007\/s00520-012-1574-9","journal-title":"Support Care Cancer"},{"key":"5012_CR56","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1139\/cjpp-2016-0346","volume":"95","author":"Y Lu","year":"2017","unstructured":"Lu Y, Anderson HD (2017) Cannabinoid signaling in health and disease. Can J Physiol Pharmacol 95:311\u2013327. \nhttps:\/\/doi.org\/10.1139\/cjpp-2016-0346","journal-title":"Can J Physiol Pharmacol"},{"key":"5012_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","volume":"64","author":"R Mechoulam","year":"2013","unstructured":"Mechoulam R, Parker LA (2013) The endocannabinoid system and the brain. Annu Rev Psychol 64:21\u201347. \nhttps:\/\/doi.org\/10.1146\/annurev-psych-113011-143739","journal-title":"Annu Rev Psychol"},{"key":"5012_CR58","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejphar.2013.09.068","volume":"722","author":"KA Sharkey","year":"2014","unstructured":"Sharkey KA, Darmani NA, Parker LA (2014) Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system. Eur J Pharmacol 722:134\u2013146. \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2013.09.068","journal-title":"Eur J Pharmacol"},{"key":"5012_CR59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejphar.2014.01.047","volume":"727","author":"Y Zheng","year":"2014","unstructured":"Zheng Y, Wang X-L, Moa F-F, Li M (2014) Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system. Eur J Pharmacol 727:99\u2013105. \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2014.01.047","journal-title":"Eur J Pharmacol"},{"key":"5012_CR60","doi-asserted-by":"publisher","unstructured":"Smith LA, Azariah F, Lavender VTC, et al (2015). Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database of Systematic Reviews Issue 11. Art. No.: CD009464. \nhttps:\/\/doi.org\/10.1002\/14651858.CD009464.pub2","DOI":"10.1002\/14651858.CD009464.pub2"},{"key":"5012_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejim.2018.01.003","volume":"49","author":"DI Abrams","year":"2018","unstructured":"Abrams DI (2018) The therapeutic effects of Cannabis and cannabinoids: an update from the National Academies of Sciences, Engineering and Medicine report. Eur J Intern Med 49:7\u201311. \nhttps:\/\/doi.org\/10.1016\/j.ejim.2018.01.003","journal-title":"Eur J Intern Med"},{"key":"5012_CR62","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00520-012-1493-9","volume":"21","author":"C Farrell","year":"2013","unstructured":"Farrell C, Brearley SG, Pilling M, Molassiotis A (2013) The impact of chemotherapy-related nausea on patients\u2019 nutritional status, psychological distress and quality of life. Support Care Cancer 21:59\u201366. \nhttps:\/\/doi.org\/10.1007\/s00520-012-1493-9","journal-title":"Support Care Cancer"},{"key":"5012_CR63","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejphar.2013.09.072","volume":"722","author":"PLR Andrews","year":"2014","unstructured":"Andrews PLR, Sanger GJ (2014) Nausea and the quest for the perfect anti-emetic. Eur J Pharmacol 722:108\u2013121. \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2013.09.072","journal-title":"Eur J Pharmacol"},{"key":"5012_CR64","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.2147\/DDDT.S125743","volume":"11","author":"M Malamood","year":"2017","unstructured":"Malamood M, Roberts A, Kataria R, Parkman H, Schey R (2017) Mirtazapine for symptom control in refractory gastroparesis. Drug Des Devel Ther 11:1035\u20131041. \nhttps:\/\/doi.org\/10.2147\/DDDT.S125743","journal-title":"Drug Des Devel Ther"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-05012-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-019-05012-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-05012-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T23:16:46Z","timestamp":1596583006000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-019-05012-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["5012"],"URL":"https:\/\/doi.org\/10.1007\/s00520-019-05012-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,6]]},"assertion":[{"value":"10 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Rita J. Wickham has received speaker\u2019s honoraria from Insys Therapeutics and advisory board compensation from Helsinn Healthcare SA. There is no primary data associated with this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}